Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field is a research paper published in The Lancet Microbe (2025). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: 2R24AI13661806
The Francis Crick Institute
Grant: CC2223
Wellcome Trust
Grant: 110110/Z/15/Z
Wellcome Trust
Grant: 220549/Z/20/Z
World Health Organization
Grant: 001
Wellcome Trust
Grant: unidentified
unidentified
Ministerie van Volksgezondheid, Welzijn en Sport
National Institutes of Health
Secretaría Nacional de Ciencia, Tecnología e Innovación
UCLH Biomedical Research Centre
Wellcome Trust
National Institute for Health and Care Research
Fields of Study
MeSH Terms
Keywords